Expert Commentary
View AllPublications
Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
The role of core strengthening for chronic low back pain.
Buckley DI, Calvert JF, Lapidus JA, et al.
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
Beck JG, Clapp JD.
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Garven A, Brady S, Wood S, Hatfield M, Bestard J, Korngut L, Toth C.
Pain Res Manag. 2011...
Pain Res Manag. 2011...
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
Barth KS, Becker WC, Wiedemer NL, Mavandadi S, Oslin DW, Meghani SH, Gallagher RM.
J Addict...
J Addict...
The role of core strengthening for chronic low back pain.
Akuthota V, Standaert CJ, Chimes GP.
PM R. 2011 Jul;3(7):664-70.
PM R. 2011 Jul;3(7):664-70.






Ethical Issues in Opioid Prescribing for Chronic Pain
Jane C. Ballantyne, MD
Penn Pain Medicine Center
Department of Anesthesiology and Critical Care
Philadelphia, PA
The evolution of medicine has shifted medical decision making from a physician-driven process to a guidance–cooperation model of care, in which patients choose among potential treatment options based on recommendations from healthcare providers. Such a model can be problematic when patients and clinicians do not agree on the appropriate course of therapy. This issue compounded when considering long-term treatment with potentially addictive medications, such as opioids. Most would argue that clinician is often better positioned to assess potential risks and benefits for the patient, and thus is under no obligation to prescribe unless the medication is the most likely approach to achieve mutually defined therapeutic goals. Further ethical issues may arise, however, when the desired treatment strategy produces a significant economic or social burden for society as a whole, particularly in light of increasing rates of opioid abuse and related overdose. Nevertheless, the clinician’s primary duty is to the patient, and therapy should be selected based on the relative risks and benefits of all available treatment options.
References